Neil H. Shuey
St Vincent's Hospital Melbourne
Fitzroy, NSW, Australia
Fitzroy, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Mind the gap: making headway in functional visual loss.
Journal: Eye (London, England)
Published: July 01, 2026
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.
Journal: Journal of neurology
Published: November 01, 2025
Predicting disease progression in multiple sclerosis with clinically accessible information and technology.
Journal: Journal of neurology
Published: September 16, 2025
A tailored cognitive behavioural therapy intervention for depression in those newly diagnosed with multiple sclerosis (ACTION-MS): A randomised, assessor-blinded, active comparator trial.
Journal: Journal of affective disorders
Published: May 04, 2025
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data.
Journal: NPJ digital medicine
Published: February 13, 2025
Orbital Inflammatory Manifestations in a Patient With VEXAS (Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic) Syndrome.
Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Published: November 27, 2024
Longitudinal visual outcomes in idiopathic intracranial hypertension: the role of early prognostic indicators and risk stratification in disease management.
Journal: Journal of neurology
Published: July 23, 2024
Developing a Quality Assurance Framework for Neuro-Ophthalmology Using a Multisite Data Registry.
Journal: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Published: July 20, 2023
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Journal: Brain : a journal of neurology
Published: March 01, 2023
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 28, 2023
Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data.
Journal: BMJ neurology open
Published: April 13, 2022
Last Updated: 09/26/2026